Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Kiyozuka, Yasuhiko"'
Autor:
Kiyozuka, Yasuhiko *, Nakagawa, Hiroyuki, Uemura, Yoshiko, Senzaki, Hideto, Yamamoto, Akitsugu, Noguchi, Taketoshi, Mizuta, Hirohisa, Nakanishi, Kohji, Nakano, Shiro, Tsubura, Airo
Publikováno v:
In Cancer Genetics and Cytogenetics 2001 127(1):7-15
Autor:
Yoshizawa, Katsuhiko, Yang, Jihong, Senzaki, Hideto, Uemura, Yoshiko, Kiyozuka, Yasuhiko, Shikata, Nobuaki, Oishi, Yuji, Miki, Hirohiko, Tsubura, Airo
Publikováno v:
In Experimental Eye Research December 2000 71(6):629-635
Autor:
Kiyozuka, Yasuhiko1,2 kiyozuka@takii.kmu.ac.jp, Yamamoto, Masashi3, Matsuyama, Tomohiko1, Miki, Katsuaki2, Tsukamoto, Reiko2, Shimano, Naoto2, Tsubura, Airo2
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Mar2006, Vol. 2 Issue 1, p64-67. 4p. 3 Color Photographs.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Senzaki, Hideto, Kiyozuka, Yasuhiko, Mizuoka, Hiroshi, Yamamoto, Daigo, Ueda, Satoshi, Izumi, Haruaki, Tsubura, Airo
Publikováno v:
Pathology International. Feb99, Vol. 49 Issue 2, p164-169. 6p.
Autor:
Senzaki, Hideto, Kiyozuka, Yasuhiko, Eumura, Yoshiko, Shikata, Nobuaki, Ueda, Satoshi, Tsubura, Airo
Publikováno v:
Pathology International. Mar1998, Vol. 48 Issue 3, p230. 7p. 13 Black and White Photographs, 1 Diagram, 2 Charts, 1 Graph.
Autor:
Noda, Tsuneo, Adachi, Susumu, Ito, Kimihiko, Itani, Yoshio, Tamori, Nobuya, Kiyozuka, Yasuhiko
Publikováno v:
奈良医学雑誌. 45(3):273-285
We investigated the in vitro cytotoxic effects of CPT-11, a new derivative of camptothecin, and its metabolizable form in vivo, SN-38, on cisplatin-resistant (SHIN-3) and -sensitive (MN-1) ovarian cancer cell lines using the MTT assay. We also attemp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::ddd23f83e1f693190101388786b01e93
http://hdl.handle.net/10564/1656
http://hdl.handle.net/10564/1656
Publikováno v:
奈良医学雑誌. 45(3):301-310
Etoposide is becoming important in primary and salvage therapy for ovarian cancer. In the present study, we administered etoposide (100-300 mg/subject) intraperitoneally to six patients suffering from cancerous peritonitis, particularly that resultin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::3fc63929bbaa1ce1cb4488bacd19eb3a
http://hdl.handle.net/10564/1691
http://hdl.handle.net/10564/1691
Publikováno v:
Chemosensitivity: Volume II; 2005, p97-108, 12p
Autor:
Kiyozuka, Yasuhiko, Takemoto, Kuniko, Yamamoto, Akitsugu, Guttmann, Peter, Tsubura, Airo, Kihara, Hiroshi
Publikováno v:
AIP Conference Proceedings; 2000, Vol. 507 Issue 1, p153, 6p